Pathological tau disrupts ongoing network activity
- PMID: 25704951
- DOI: 10.1016/j.neuron.2015.01.025
Pathological tau disrupts ongoing network activity
Abstract
Pathological tau leads to dementia and neurodegeneration in tauopathies, including Alzheimer's disease. It has been shown to disrupt cellular and synaptic functions, yet its effects on the function of the intact neocortical network remain unknown. Using in vivo intracellular and extracellular recordings, we measured ongoing activity of neocortical pyramidal cells during various arousal states in the rTg4510 mouse model of tauopathy, prior to significant cell death, when only a fraction of the neurons show pathological tau. In transgenic mice, membrane potential oscillations are slower during slow-wave sleep and under anesthesia. Intracellular recordings revealed that these changes are due to longer Down states and state transitions of membrane potentials. Firing rates of transgenic neurons are reduced, and firing patterns within Up states are altered, with longer latencies and inter-spike intervals. By changing the activity patterns of a subpopulation of affected neurons, pathological tau reduces the activity of the neocortical network.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Altered Intrinsic Pyramidal Neuron Properties and Pathway-Specific Synaptic Dysfunction Underlie Aberrant Hippocampal Network Function in a Mouse Model of Tauopathy.J Neurosci. 2016 Jan 13;36(2):350-63. doi: 10.1523/JNEUROSCI.2151-15.2016. J Neurosci. 2016. PMID: 26758828 Free PMC article.
-
Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.J Neurosci. 2020 Apr 22;40(17):3491-3501. doi: 10.1523/JNEUROSCI.2880-19.2020. Epub 2020 Apr 7. J Neurosci. 2020. PMID: 32265258 Free PMC article.
-
Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.Respir Physiol Neurobiol. 2011 Sep 15;178(2):290-303. doi: 10.1016/j.resp.2011.06.030. Epub 2011 Jul 6. Respir Physiol Neurobiol. 2011. PMID: 21763469
-
Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy.Biochem Soc Trans. 2010 Apr;38(2):564-70. doi: 10.1042/BST0380564. Biochem Soc Trans. 2010. PMID: 20298222 Review.
-
Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.Neurol Sci. 2007 Apr;28(2):63-71. doi: 10.1007/s10072-007-0789-x. Neurol Sci. 2007. PMID: 17464468 Review.
Cited by
-
New Therapeutics in Alzheimer's Disease Longitudinal Cohort study (NTAD): study protocol.BMJ Open. 2022 Dec 15;12(12):e055135. doi: 10.1136/bmjopen-2021-055135. BMJ Open. 2022. PMID: 36521898 Free PMC article.
-
From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer's and Parkinson's diseases.Neural Regen Res. 2022 Dec;17(12):2606-2614. doi: 10.4103/1673-5374.336138. Neural Regen Res. 2022. PMID: 35662189 Free PMC article. Review.
-
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.Mol Neurodegener. 2023 Apr 21;18(1):27. doi: 10.1186/s13024-023-00617-4. Mol Neurodegener. 2023. PMID: 37085942 Free PMC article. Review.
-
Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer's disease pathology.Sci Rep. 2017 Oct 27;7(1):14189. doi: 10.1038/s41598-017-13839-6. Sci Rep. 2017. PMID: 29079799 Free PMC article.
-
Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.Eur J Neurosci. 2016 Dec;44(12):3056-3066. doi: 10.1111/ejn.13442. Epub 2016 Nov 12. Eur J Neurosci. 2016. PMID: 27748574 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases